PCDH9 (protocadherin 9)

2012-06-01   Dessen P  

Identity

HGNC
LOCATION
13q21.32
LOCUSID
ALIAS
-
FUSION GENES

Other Information

Locus ID:

NCBI: 5101
MIM: 603581
HGNC: 8661
Ensembl: ENSG00000184226

Variants:

dbSNP: 5101
ClinVar: 5101
TCGA: ENSG00000184226
COSMIC: PCDH9

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000184226ENST00000377861Q5VT82
ENSG00000184226ENST00000377865Q9HC56
ENSG00000184226ENST00000377865X5D7N0
ENSG00000184226ENST00000456367B7ZM79
ENSG00000184226ENST00000544246Q9HC56
ENSG00000184226ENST00000614931A0A087WZW0

Expression (GTEx)

0
1
2
3
4
5
6
7
8
9
10

References

Pubmed IDYearTitleCitations
389276382024Expression of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) Candidate Genes EDA2R, PCDH9, and TRAF7 in Normal Human Kidney Development and CAKUT.1
389276382024Expression of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) Candidate Genes EDA2R, PCDH9, and TRAF7 in Normal Human Kidney Development and CAKUT.1
350846532022COP1 Acts as a Ubiquitin Ligase for PCDH9 Ubiquitination and Degradation in Human Glioma.2
350846532022COP1 Acts as a Ubiquitin Ligase for PCDH9 Ubiquitination and Degradation in Human Glioma.2
310591162019Semaphorin 3A (SEMA3A), protocadherin 9 (PCdh9), and S100 calcium binding protein A3 (S100A3) as potential biomarkers of carcinogenesis and chemoresistance of different neoplasms, including ovarian cancer - review of literature.10
310591162019Semaphorin 3A (SEMA3A), protocadherin 9 (PCdh9), and S100 calcium binding protein A3 (S100A3) as potential biomarkers of carcinogenesis and chemoresistance of different neoplasms, including ovarian cancer - review of literature.10
289905942018The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder.20
289905942018The Gene Encoding Protocadherin 9 (PCDH9), a Novel Risk Factor for Major Depressive Disorder.20
280559662017Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.18
287914092017PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma.12
280559662017Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.18
287914092017PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma.12
258699282015Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer.22
258699282015Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer.22
251726622014Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma.26

Citation

Dessen P

PCDH9 (protocadherin 9)

Atlas Genet Cytogenet Oncol Haematol. 2012-06-01

Online version: http://atlasgeneticsoncology.org/gene/52752/pcdh9-(protocadherin-9)